vs
Orthofix Medical Inc.（OFIX）与Riot Platforms, Inc.（RIOT）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Riot Platforms, Inc.的1.4倍（$219.9M vs $152.8M），Orthofix Medical Inc.净利率更高（-1.0% vs -452.0%，领先451.0%），Riot Platforms, Inc.同比增速更快（7.2% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-774.3M），过去两年Riot Platforms, Inc.的营收复合增速更高（38.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Riot Platforms是美国领先的比特币挖矿企业，在北美地区运营多座大规模高能效的加密货币矿场，同时布局区块链相关基础设施业务，长期持有比特币作为核心储备资产，专注于数字资产生态相关业务的长期发展。
OFIX vs RIOT — 直观对比
营收规模更大
OFIX
是对方的1.4倍
$152.8M
营收增速更快
RIOT
高出5.2%
2.0%
净利率更高
OFIX
高出451.0%
-452.0%
自由现金流更多
OFIX
多$791.1M
$-774.3M
两年增速更快
RIOT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $152.8M |
| 净利润 | $-2.2M | $-690.7M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | -447.9% |
| 净利率 | -1.0% | -452.0% |
| 营收同比 | 2.0% | 7.2% |
| 净利润同比 | 92.4% | -606.3% |
| 每股收益（稀释后） | $-0.05 | $-1.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXRIOT
| Q4 25 | $219.9M | $152.8M | ||
| Q3 25 | $205.6M | $180.2M | ||
| Q2 25 | $203.1M | $153.0M | ||
| Q1 25 | $193.6M | $161.4M | ||
| Q4 24 | $215.7M | $142.6M | ||
| Q3 24 | $196.6M | $84.8M | ||
| Q2 24 | $198.6M | $70.0M | ||
| Q1 24 | $188.6M | $79.3M |
净利润OFIXRIOT
| Q4 25 | $-2.2M | $-690.7M | ||
| Q3 25 | $-22.8M | $104.5M | ||
| Q2 25 | $-14.1M | $219.5M | ||
| Q1 25 | $-53.1M | $-296.4M | ||
| Q4 24 | $-29.1M | $136.4M | ||
| Q3 24 | $-27.4M | $-154.4M | ||
| Q2 24 | $-33.4M | $-84.4M | ||
| Q1 24 | $-36.0M | $211.8M |
毛利率OFIXRIOT
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXRIOT
| Q4 25 | 0.2% | -447.9% | ||
| Q3 25 | -8.3% | 44.4% | ||
| Q2 25 | -7.9% | — | ||
| Q1 25 | -25.2% | -144.9% | ||
| Q4 24 | -5.3% | — | ||
| Q3 24 | -9.6% | -143.3% | ||
| Q2 24 | -12.5% | -167.2% | ||
| Q1 24 | -15.6% | — |
净利率OFIXRIOT
| Q4 25 | -1.0% | -452.0% | ||
| Q3 25 | -11.1% | 58.0% | ||
| Q2 25 | -6.9% | 143.4% | ||
| Q1 25 | -27.4% | -183.6% | ||
| Q4 24 | -13.5% | 95.7% | ||
| Q3 24 | -13.9% | -182.1% | ||
| Q2 24 | -16.8% | -120.6% | ||
| Q1 24 | -19.1% | 267.1% |
每股收益（稀释后）OFIXRIOT
| Q4 25 | $-0.05 | $-1.89 | ||
| Q3 25 | $-0.57 | $0.26 | ||
| Q2 25 | $-0.36 | $0.58 | ||
| Q1 25 | $-1.35 | $-0.90 | ||
| Q4 24 | $-0.76 | $0.39 | ||
| Q3 24 | $-0.71 | $-0.54 | ||
| Q2 24 | $-0.88 | $-0.32 | ||
| Q1 24 | $-0.95 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $233.5M |
| 总债务越低越好 | — | $840.8M |
| 股东权益账面价值 | $450.0M | $2.9B |
| 总资产 | $850.6M | $3.9B |
| 负债/权益比越低杠杆越低 | — | 0.29× |
8季度趋势，按日历期对齐
现金及短期投资OFIXRIOT
| Q4 25 | $82.0M | $233.5M | ||
| Q3 25 | $62.9M | $330.7M | ||
| Q2 25 | $65.6M | $255.4M | ||
| Q1 25 | $58.0M | $163.7M | ||
| Q4 24 | $83.2M | $277.9M | ||
| Q3 24 | $30.1M | $355.7M | ||
| Q2 24 | $26.4M | $481.2M | ||
| Q1 24 | $27.0M | $688.5M |
总债务OFIXRIOT
| Q4 25 | — | $840.8M | ||
| Q3 25 | $157.2M | $5.3M | ||
| Q2 25 | $157.0M | $5.3M | ||
| Q1 25 | $156.9M | $5.3M | ||
| Q4 24 | $157.0M | $584.6M | ||
| Q3 24 | $118.5M | $5.7M | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXRIOT
| Q4 25 | $450.0M | $2.9B | ||
| Q3 25 | $442.5M | $3.5B | ||
| Q2 25 | $458.3M | $3.3B | ||
| Q1 25 | $458.3M | $2.9B | ||
| Q4 24 | $503.1M | $3.1B | ||
| Q3 24 | $525.9M | $2.7B | ||
| Q2 24 | $546.0M | $2.6B | ||
| Q1 24 | $570.3M | $2.5B |
总资产OFIXRIOT
| Q4 25 | $850.6M | $3.9B | ||
| Q3 25 | $832.6M | $4.5B | ||
| Q2 25 | $837.2M | $4.3B | ||
| Q1 25 | $823.1M | $3.7B | ||
| Q4 24 | $893.3M | $3.9B | ||
| Q3 24 | $867.9M | $2.9B | ||
| Q2 24 | $882.0M | $2.7B | ||
| Q1 24 | $906.0M | $2.6B |
负债/权益比OFIXRIOT
| Q4 25 | — | 0.29× | ||
| Q3 25 | 0.36× | 0.00× | ||
| Q2 25 | 0.34× | 0.00× | ||
| Q1 25 | 0.34× | 0.00× | ||
| Q4 24 | 0.31× | 0.19× | ||
| Q3 24 | 0.23× | 0.00× | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-572.9M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-774.3M |
| 自由现金流率自由现金流/营收 | 7.6% | -506.6% |
| 资本支出强度资本支出/营收 | 4.9% | 131.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-1.4B |
8季度趋势，按日历期对齐
经营现金流OFIXRIOT
| Q4 25 | $27.7M | $-572.9M | ||
| Q3 25 | $12.4M | $-114.0M | ||
| Q2 25 | $11.6M | $-231.3M | ||
| Q1 25 | $-18.4M | $-122.1M | ||
| Q4 24 | $23.7M | $-255.1M | ||
| Q3 24 | $11.7M | $-56.3M | ||
| Q2 24 | $9.0M | $-42.5M | ||
| Q1 24 | $-18.6M | $-57.9M |
自由现金流OFIXRIOT
| Q4 25 | $16.8M | $-774.3M | ||
| Q3 25 | $2.5M | $-139.7M | ||
| Q2 25 | $4.5M | $-291.7M | ||
| Q1 25 | $-25.1M | $-154.9M | ||
| Q4 24 | $15.2M | $-495.4M | ||
| Q3 24 | $6.3M | $-127.6M | ||
| Q2 24 | $-360.0K | $-96.1M | ||
| Q1 24 | $-29.1M | $-115.2M |
自由现金流率OFIXRIOT
| Q4 25 | 7.6% | -506.6% | ||
| Q3 25 | 1.2% | -77.5% | ||
| Q2 25 | 2.2% | -190.7% | ||
| Q1 25 | -13.0% | -96.0% | ||
| Q4 24 | 7.0% | -347.5% | ||
| Q3 24 | 3.2% | -150.5% | ||
| Q2 24 | -0.2% | -137.2% | ||
| Q1 24 | -15.4% | -145.2% |
资本支出强度OFIXRIOT
| Q4 25 | 4.9% | 131.8% | ||
| Q3 25 | 4.8% | 14.3% | ||
| Q2 25 | 3.5% | 39.5% | ||
| Q1 25 | 3.5% | 20.4% | ||
| Q4 24 | 4.0% | 168.6% | ||
| Q3 24 | 2.7% | 84.1% | ||
| Q2 24 | 4.7% | 76.5% | ||
| Q1 24 | 5.6% | 72.3% |
现金转化率OFIXRIOT
| Q4 25 | — | — | ||
| Q3 25 | — | -1.09× | ||
| Q2 25 | — | -1.05× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -1.87× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
RIOT
| Bitcoin Mining Segment | $131.7M | 86% |
| Engineering Segment | $21.1M | 14% |
